title: Author Response: The Role of IL-18 in the Treatment of AMD.
authors.affiliation: Department of Clinical Medicine School of Medicine, Trinity College Dublin, Dublin 2, Ireland;
authors.forename: Sarah L
authors.initials: SL
authors.lastname: Doyle
authors.affiliation: Allergan Incorporated, Irvine, California, United States;
authors.forename: Francisco J
authors.initials: FJ
authors.lastname: López
authors.affiliation: Ocular Genetics Unit, Smurfit Institute of Genetics, Trinity College Dublin, Dublin 2, Ireland; and the.
authors.forename: Peter
authors.initials: P
authors.lastname: Humphries
authors.affiliation: UCL, ORBIT, Institute of Ophthalmology, London, United Kingdom.
authors.forename: Peter
authors.initials: P
authors.lastname: Adamson
authors.affiliation: Ocular Genetics Unit, Smurfit Institute of Genetics, Trinity College Dublin, Dublin 2, Ireland; and the.
authors.forename: Matthew
authors.initials: M
authors.lastname: Campbell
mesh_terms: D000818:Animals; D042783:Endothelial Cells / Q000473:pathology*; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D020382:Interleukin-18 / Q000008:administration & dosage*; D008268:Macular Degeneration / Q000188:drug therapy*; D015861:Retinal Neovascularization / Q000188:drug therapy*
chemical_list: D020382:Interleukin-18